Evidence map›Paper›PMID 42840744›Full record

ReviewBrain communications2026

The role of neurofilament light chain and other fluid biomarkers in cerebellar ataxias.

Charlotte Mouraux, Magda M Santana, Liana S Rosenthal, Andrea Cortese, Filippo M Santorelli, Puneet Opal, Giulia Coarelli

Abstract readReview
In one paragraph

Review in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Charlotte MourauxSorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, APHP, Pitié-Salpêtrière University Hospital, Paris 75013, France.ORCID https://orcid.org/0000-0001-9569-9229
Magda M SantanaSorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, APHP, Pitié-Salpêtrière University Hospital, Paris 75013, France.
Liana S RosenthalDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Andrea CorteseDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.ORCID https://orcid.org/0000-0002-2208-5311
Filippo M SantorelliNeurobiology and Molecular Medicine Unit, IRCCS Fondazione Stella Maris, Pisa 56128, Italy.ORCID https://orcid.org/0000-0002-1359-9062
Puneet OpalDenning Ataxia Center, Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Giulia CoarelliSorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, APHP, Pitié-Salpêtrière University Hospital, Paris 75013, France.

Funding

Understanding the Cellular Basis of Movement DisordersR01NS082351 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Puneet Opal · 2013 to 2026
$6.2M
Elucidating cellular mechanisms underlying neurodegenerationR01NS127204 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Puneet Opal · 2022 to 2026
$2.8M
VEGF-Mimetic Supramolecular Nanoparticles for Treating Spinocerebellar Ataxia Type 1R61NS127141 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI OPAL, PUNEET, STUPP, SAMUEL I · 2023 to 2024
$763k
NINDS NIH HHS R01 NS082351NINDS NIH HHS R01 NS127204NINDS NIH HHS R61 NS127141
6 · The paper itself

Abstract

The genetic and phenotypic heterogeneity of hereditary ataxias complicates the design of clinical trials since each ataxia progresses at different rates. Consequently, robust biomarkers are urgently needed to monitor therapeutic efficacy and safety of potential therapeutic interventions. Neurofilament light chain has emerged as a leading candidate, serving as a sensitive pharmacodynamic biomarker of neuronal injury and treatment response in neurodegenerative disorders. This review explores the utility of neurofilament light chain across various ataxias, including polyglutamine spinocerebellar ataxias, Friedreich's ataxia, multiple system atrophy, and other genetic ataxias, such as ataxias associated with

Indexed as

fluid biomarkershereditary cerebellar ataxiasneurofilament light chaintarget engagement

Identifiers

PMID42840744
PMCPMC13639701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.